Sonnet to merge into Hyperliquid Strategies, holding 12.6 million HYPE tokens and $300 million in cash
Odaily News Nasdaq-listed Sonnet BioTherapeutics announced that it will merge with Rorschach I LLC to form Hyperliquid Strategies and launch a crypto treasury strategy. The new entity will be renamed Hyperliquid Strategies and is expected to hold 12.6 million HYPE tokens and $305 million in cash, with a total valuation of approximately $888 million.
Rorschach I LLC was jointly established by Atlas Merchant Capital and Paradigm Operations and other sponsors. After the merger is completed, Hyperliquid Strategies will continue to be listed on Nasdaq and become a publicly traded company focused on crypto asset management, and the stock code will also be changed.
The transaction was supported by institutions such as Paradigm, Galaxy Digital, Pantera Capital, D1 Capital, Republic Digital and 683 Capital. (The Block)
Te puede gustar
Ganadores
Últimas noticias cripto
Unlimit lanza la plataforma de compensación descentralizada Stablecoin Stable.com
Crypto KOL paulwei ha compartido públicamente su trading en vivo en Hyperliquid, y recientemente ha realizado una orden de compra en patrón piramidal para ir largo en BTC.
Monad Chain Meme Coin CHOG se recupera del descenso de ayer, registra casi un 60% de ganancia en 24 horas
La Comisión de Valores y Futuros (SFC) advierte sobre productos de inversión sospechosos "9M AI Stable Fund" y "9M AI Strategy Fund"
Shield Protocol: El usuario deltatiger.eth ha sido atacado, perdiendo aproximadamente $330,000
Atención al cliente:@weikecs
Cooperación empresarial:@weikecs
Trading cuantitativo y CM:[email protected]
Servicios VIP:[email protected]